Immunology/Inflammation
Immunology/Inflammation(免疫及炎症)
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
- 5-Lipoxygenase(11)
- Papain(1)
- PGDS(1)
- PGE synthase(24)
- SIKs(12)
- IκB/IKK(67)
- AP-1(6)
- KEAP1-Nrf2(65)
- NOD1(1)
- TLR(140)
- NF-κB(241)
- Interleukin Related(171)
- 15-lipoxygenase(2)
- Others(63)
- Aryl Hydrocarbon Receptor(36)
- CD73(14)
- Complement System(58)
- Galectin(12)
- IFNAR(25)
- NO Synthase(77)
- NOD-like Receptor (NLR)(51)
- STING(110)
- Reactive Oxygen Species(465)
- Apoptosis(802)
- FKBP(20)
- eNOS(5)
- iNOS(29)
- nNOS(20)
- Glutathione(57)
- Adaptive Immunity(222)
- Allergy(130)
- Arthritis(34)
- Autoimmunity(190)
- Gastric Disease(101)
- Immunosuppressants(39)
- Immunotherapeutics(5)
- Innate Immunity(593)
- Pulmonary Diseases(119)
- Reactive Nitrogen Species(55)
- Reactive Sulfur Species(28)
- Specialized Pro-Resolving Mediators(50)
- Cyclic GMP-AMP Synthase(2)
- BCL6(3)
- CD20(3)
- CD22
- CD28(1)
- FAP(7)
- PSMA(7)
- Nuclear Factor of activated T Cells (NFAT)(1)
- Glycoprotein VI(1)
- Tim3(2)
- Hapten(1)
- Nectin-4(2)
Immunology/Inflammation 相关产品(4245)
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC90929 | Trofinetide (acetate) | - | >95.00% | |
一种由甘-脯-谷氨酸衍生的化合物。 | ||||
| GC90932 | Lipid 14 | 2430034-05-0 | >95.00% | |
一种可离子化的阳离子氨基脂质 | ||||
| GC90934 | 1,2,3,6,7,8-Hexachlorodibenzo-p-dioxin | 57653-85-7 | >98.00% | |
一种多氯代二苯并二噁英 | ||||
| GC90937 | 1,2,3,4,7,8,9-Heptachlorodibenzofuran | 55673-89-7 | >95.00% | |
一种类似二恶英的多氯联苯。 | ||||
| GC90938 | 1,2,3,4,7,8-Hexachlorodibenzofuran | 70648-26-9 | >90.00% | |
一种类似二恶英的多氯联苯。 | ||||
| GC90949 | Adenosine-5'-O-(3-thiotriphosphate) (sodium salt) | 88453-52-5 | >95.00% | |
一种P2Y11受体激动剂。 | ||||
| GC90964 | Lipid Catechol | 2930813-52-6 | >95.00% | |
一种用于构建脂质前药纳米组装体的脂质。 | ||||
| GC90982 | STING Agonist D61 | 2850251-27-1 | >95.00% | |
STING激动剂 | ||||
| GC90986 | LHC165 (hydrate) | - | >95.00% | |
一种TLR7激动剂 | ||||
| GC90987 | C12-SPM | 2055647-81-7 | >95.00% | |
一种分支多胺脂质 | ||||
| GC91022 | SP-A (196-215) (human) (trifluoroacetate salt) | - | >98.00% | |
一种肺表面活性物质蛋白A的多肽片段。 | ||||
| GC91034 | Lipid 16 | - | >95.00% | |
一种可离子化的阳离子氨基脂质 | ||||
| GC91044 | Bactobolamine | 78013-07-7 | >98.00% | |
一种免疫抑制剂 | ||||
| GC91050 | Bactobolin A (hydrochloride) | 73543-68-7 | >95.00% | |
一种具有抗生素和抗癌活性的微生物代谢产物。 | ||||
| GC91052 | Plipastatin A1 | 103651-09-8 | >90.00% | |
一种具有酶抑制和免疫抑制活性的脂肽。 | ||||
| GC91059 | LCC-12 (formate) | - | >98.00% | |
一种铜(II)螯合剂和二甲双胍衍生物。 | ||||
| GC91083 | Tiopronin-Cysteine Disulfide | 77591-18-5 | >95.00% | |
一种硫普罗宁的代谢产物。 | ||||
| GC91093 | MR2938 | 1044870-65-6 | >95.00% | |
一种乙酰胆碱酯酶抑制剂 | ||||
| GC91095 | Lipid AX4 | 2735814-23-8 | >95.00% | |
一种可离子化的阳离子脂质 | ||||
| GC91096 | S-72 | 2446799-14-8 | >98.00% | |
一种微管聚合抑制剂。 | ||||
| GC91099 | HUP-55 | - | >98.00% | |
一种脯氨酸内切肽酶抑制剂 | ||||
| GC91105 | Palustric Acid | 1945-53-5 | >95.00% | |
一种具有多种生物活性的二萜类化合物。 | ||||
| GC91135 | 4-(3,4-Difluorobenzo)curcumin | 1170354-22-9 | >95.00% | |
一种半合成的香豆素,具有抗寄生虫和抗癌活性。 | ||||
| GC91136 | XY-4 | 474329-47-0 | >95.00% | |
PPARγ的激动剂 | ||||
